FSMAX
Price
$92.35
Change
+$0.18 (+0.20%)
Updated
Jun 27 closing price
Net Assets
37.61B
SBMAX
Price
$34.64
Change
+$0.04 (+0.12%)
Updated
Jun 27 closing price
Net Assets
1.67B
Interact to see
Advertisement

FSMAX vs SBMAX

Header iconFSMAX vs SBMAX Comparison
Open Charts FSMAX vs SBMAXBanner chart's image
Fidelity Extended Market Index
Price$92.35
Change+$0.18 (+0.20%)
VolumeN/A
Net Assets37.61B
ClearBridge Mid Cap A
Price$34.64
Change+$0.04 (+0.12%)
VolumeN/A
Net Assets1.67B
FSMAX vs SBMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. SBMAX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and SBMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 37.6B vs. SBMAX (1.67B). FSMAX pays higher dividends than SBMAX: FSMAX (0.50) vs SBMAX (0.04). FSMAX was incepted earlier than SBMAX: FSMAX (14 years) vs SBMAX (27 years). SBMAX (1.16) is less costly to investors than FSMAX (0.04). SBMAX is a more actively managed with annual turnover of: 36.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than SBMAX: FSMAX (0) vs SBMAX (1000). FSMAX annual gain was more profitable for investors over the last year : 15.55 vs. SBMAX (3.97). FSMAX return over 5 years is better than : 66.96 vs. SBMAX (18.07).
FSMAXSBMAXFSMAX / SBMAX
Total Expense Ratio0.041.163%
Annual Report Gross Expense Ratio0.041.163%
Fund Existence14 years27 years-
Gain YTD1.6182.30470%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets37.6B1.67B2,256%
Annual Yield % from dividends0.500.041,171%
Returns for 1 year15.553.97391%
Returns for 3 years48.978.67565%
Returns for 5 years66.9618.07371%
Returns for 10 years75.609.12829%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNFP109.560.32
+0.30%
Pinnacle Financial Partners
T28.080.08
+0.29%
AT&T
IMCR32.02N/A
N/A
Immunocore Holdings plc
ARCT13.33-1.08
-7.49%
Arcturus Therapeutics Holdings
SCYX0.69-0.06
-7.70%
SCYNEXIS